To keep advocating for others, I need to afford my medication.
To keep advocating for others, I need to afford my medications. But with prices so high, there are no guarantees I’ll be able to afford the medicine I need to live.
STATEMENT: P4AD Applauds FDA’s Approval Of First Interchangeable Biosimilar Insulin, Calls For Affordable Insulin For All
The FDA’s approval of Semglee as an interchangeable biosimilar to Lantus is an important step forward on the road to real competition.
NEW ANALYSIS: Drug Companies Continue To Hike Prices At Will; Congress Must Act
Patients For Affordable Drugs’ Analysis Highlights Need For Medicare Negotiation For All Drugs
Analysis: DRUG COMPANIES CONTINUE TO HIKE PRICES AT WILL
Take a look at this year's price hikes to see why Congress must act now.
July 2021 Price Hikes Methodology
P4AD analyzed the wholesale acquisition cost (WAC) data for the 170 unique National Drug Codes (NDCs) with price hikes greater than 1% or $1 that were posted between July 1 and July 6.
Luxury pricing for a necessity.
This insulin is currently priced at almost $300 per bottle. It is luxury pricing for a medication that I literally cannot live without.
Changes are terrifying because of the high price of insulin
I have to scrimp and save to afford to eat. But I know other senior citizens who are much worse off — some are even eating cat food to be able to afford their drugs.
TODAY: Patient, P4AD Founder David Mitchell Tells Senate Judiciary Subcommittee That Anticompetitive Pharma Industry Practices Stifle Innovation, Drive Up Prices
Mitchell Urges Congress To Pass Bipartisan Solutions To Address Anticompetitive Behavior And To Allow Medicare To Negotiate Lower Drug Prices
